Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Related Citations for PubMed (Select 22177324)

1.

[The thalidomide experience: review of its effects 50 years later].

Martínez-Frías ML.

Med Clin (Barc). 2012 Jun 2;139(1):25-32. doi: 10.1016/j.medcli.2011.10.011. Epub 2011 Dec 15. Review. Spanish.

PMID:
22177324
2.

Les bébés du thalidomide.

Lefrère JJ, Berche P.

Presse Med. 2011 Mar;40(3):301-8. doi: 10.1016/j.lpm.2010.04.025. Epub 2010 Sep 17. No abstract available.

PMID:
20850260
3.

[Thalidomide--a dreaded drug with new indications].

Waage A, Seidel C.

Tidsskr Nor Laegeforen. 2001 Oct 20;121(25):2954-7. Review. Norwegian.

PMID:
11715779
4.

[Thalidomide--failure or success? A controversial drug during the last fifty years--the pendulum swings--a renaissance for thalidomide?].

Dalhoff KP, Poulsen HE.

Ugeskr Laeger. 2000 Jan 3;162(1):52-3. Danish. No abstract available.

PMID:
10658498
5.

[Reinventing thalidomide under high supervision].

Monneret C.

Ann Pharm Fr. 2010 May;68(3):133-5. doi: 10.1016/j.pharma.2010.05.001. French. No abstract available.

PMID:
20569769
6.

The thalidomide syndrome: risks of exposure and spectrum of malformations.

Newman CG.

Clin Perinatol. 1986 Sep;13(3):555-73. Review.

PMID:
3533365
7.

[Thalidomide epidemics: 50 years after].

Sípek A Jr, Sípek A, Maňáková E.

Cas Lek Cesk. 2012;151(12):579-81. Czech.

PMID:
23387816
8.

Thalidomide: the tragedy of birth defects and the effective treatment of disease.

Kim JH, Scialli AR.

Toxicol Sci. 2011 Jul;122(1):1-6. doi: 10.1093/toxsci/kfr088. Epub 2011 Apr 19. Erratum in: Toxicol Sci. 2012 Feb;125(2):613.

9.

Thalidomide: was the tragedy preventable?

Dally A.

Lancet. 1998 Apr 18;351(9110):1197-9. No abstract available.

PMID:
9643709
10.

[The thalidomide story: the Israeli chapter].

Dolev E.

Harefuah. 2001 Aug;140(8):795-7. Hebrew. No abstract available.

PMID:
11547491
12.
14.

The schizophrenic career of a "monster drug".

Silverman WA.

Pediatrics. 2002 Aug;110(2 Pt 1):404-6. No abstract available.

PMID:
12165600
15.

Deciphering the mystery of thalidomide teratogenicity.

Ito T, Handa H.

Congenit Anom (Kyoto). 2012 Mar;52(1):1-7. doi: 10.1111/j.1741-4520.2011.00351.x. Review.

PMID:
22348778
16.

Was the thalidomide tragedy preventable?

Critchley EM.

Lancet. 1998 May 23;351(9115):1591. No abstract available.

PMID:
10326578
17.

[Thalidomide: an unfinished history].

Papaseit E, García-Algar O, Farré M.

An Pediatr (Barc). 2013 May;78(5):283-7. doi: 10.1016/j.anpedi.2012.11.022. Epub 2013 Jan 16. Spanish. No abstract available.

18.

A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.

Webster WS, Brown-Woodman PD, Ritchie HE.

Int J Dev Biol. 1997 Apr;41(2):329-35. Review.

19.

What can we learn from the thalidomide experience: an ophthalmologic perspective.

Miller MT, Strömland KK.

Curr Opin Ophthalmol. 2011 Sep;22(5):356-64. doi: 10.1097/ICU.0b013e3283499f24. Review.

20.

Thalidomide, a current teratogen in South America.

Castilla EE, Ashton-Prolla P, Barreda-Mejia E, Brunoni D, Cavalcanti DP, Correa-Neto J, Delgadillo JL, Dutra MG, Felix T, Giraldo A, Juarez N, Lopez-Camelo JS, Nazer J, Orioli IM, Paz JE, Pessoto MA, Pina-Neto JM, Quadrelli R, Rittler M, Rueda S, Saltos M, Sánchez O, Schüler L.

Teratology. 1996 Dec;54(6):273-7.

PMID:
9098920
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk